Cullinan Oncology Announces the Appointment of David P. Ryan

CAMBRIDGE, Mass., Nov. 02, 2022 -- Cullinan Oncology, Inc.  , a biopharmaceutical company focused on modality-agnostic targeted oncology for patients with cancer, today announced that David P.... | November 2, 2022

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , Massachusetts , American , Ansbert Gadicke , David Ryan , Tony Rosenberg , Davidp Ryan , Medicine Department , Presbyterian Medical Center , Cancer Center , American Society For Clinical Oncology , Cullinan Oncology Inc , Columbia College Of Physicians , Nasdaq , Cullinan Oncology , Massachusetts General Hospital , Clinical Director , Columbia College , Columbia Presbyterian Medical Center , Internal Medicine , Shelby Memorial Professor , Cancer Therapeutics , Harvard Medical , American Society , Bioimpact Capital , Cullinan Oncology Board , Managing Partner , Oncology Impact Funds , Managing Director , Nc Stock Exchange , News , Information , Press Release , 022 , Cullinan , Iopharmaceutical , Company , Ocused , N , Argeted , Ncology , Or , Patients , Ith , Oday , Nnounced , Hat , Avid Cgem Us2300311063 ,